The primary structures of the N-linked oligosaccharides from normal human serum IgAl were determined by a combination of sequential exoglycosidase digestion, Bio-Gel P-4 chromatography, anion-exchange chromatography and one-dimensional n.m.r. spectroscopy. Three major N-linked disialylated biantennary-complex-type structures were found (55%). The remaining N-linked oligosaccharides consisted of at least nine further structures, some of which (7 %) were of the triantennary type and included disialylated triantennary oligosaccharides with outer-arm fucose substitution ]. Compared with IgG, the N-glycan structures on IgA are more completely processed: the outer arms have a higher proportion of galactose and sialic acid, and only trace levels of incompletely galactosylated oligosaccharides, commonly found on IgG, were detected.
INTRODUCTION
'Relatively little is known about the functions of IgA despite the fact that it is a major isotype in normal human serum (,0.5-4 .0 mg/ml). Previous studies suggested that the dominanftrole of serum IgA was the removal of antigenic substances without the generation of an inflammatory response (Van Epps and Williams, 1976; Wilton, 1978) . However, more recent work has shown that IgA can activate complement and will efficiently trigger cell-mediated events (Hiemstra et al., 1987; Yeaman and Kerr, 1987; Gorter et al., 1988; Kerr, 1990 ; Griffiss and Goroff, 1983) . IgA receptors have been detected on human neutrophils, monocytes, macrophages, subpopulations of T-cells, B-cells and NK cells (Lawrence et al., 1975; Fanger and Lydyard, 1981; Millet et al., 1988; Chevalier et al., 1989; Fortune et al., 1990; Maliszewski et al., 1990; Mazengera and Kerr, 1990 ; Monteiro et al., 1990 ; Stewart and Kerr, 1990) . Soluble IgA-binding factors in serum may regulate a class-specific antibody response similarly to IgE-binding factors [Kerr (1990) and references therein].
There are two subclasses of human IgA: IgAl (80-90% of total serum IgA) and IgA2. The major structural difference between these two subclasses is that IgAl has an additional 18-amino acid 0-glycosylated hinge region (Pro-223-Ser-242) composed exclusively of proline, serine and threonine, which is [NeuAc2a3(6)]2Gal,83GalNAc and 9 % were [NeuAc2a3(6)]-Gal,84GlcNAcfl6[NeuAc2a3(6)Gal,/3]GalNAc, and 27 %'were monosialylated. The N-linked glycosylation of both serum IgAl and IgG isolated from a group of six normal individuals was compared with that from ten patients with rheumatoid arthritis (RA). In contrast with the hypogalactosylation found in IgG from diseased sera, there was no evidence of an equivalent decrease in the galactosylation of the IgAl oligosaccharides. In addition, the N-glycosylation of IgAl was remarkably consistent within the group of normal individuals. These data suggest that incomplete galactosylation of N-linked glycans and its augmentation in RA does not extend to IgAl and that the RA-associated galactosyltransferase deficiency may be restricted to cells producing y-chain. located between the Cal and Ca2 domains. IgAl contains two N-glycosylation sites per a-chain in the Fc region of the protein, located in the Ca2 (Asn-263) and Ca3 (Asn-459) domains , whereas IgA2 contains four sites per achain with glycosylation sequons in the Cal (Asn-166), Ca2 (Asn-263, -337) and Ca3 (Asn-459) domains (Torano and Putnam, 1978) . The IgA2 m2 allotype contains a further glycosylation sequon at Asn-211 in the Cal (Tsuzukida et al., 1979) .
Previous analyses of the oligosaccharide composition of IgAl and IgA2 from a group of individuals (Tomana et al., 1976) were consistent with the presence of complex-type structures. Significant variation was found between the samples, suggesting that IgA glycoforms may vary between individuals. Myeloma IgA (Baenziger and Kornfeld, 1974a) contained two N-linked biantennary complex-type structures with sialic acid linked a2-6. Analysis of the 0-linked glycans (attached to five substituted serines) from the human myeloma IgAl by Baenziger and Kornfield (1974b) showed that four of the hinge-region structures were neutral Gal/J3GalNAc. In addition, GalNAcal-O-Ser was present at Ser-224, and no sialylated 0-linked saccharides were found. More recently we have reported the structures of 0-linked glycans from normal serum IgAl released by f-elimination (Field et al., 1989) . In this case it was found that the ratio of maintained at 4:1 but additionally that Galfl3GalNAc was present as both mono-and di-sialylated forms.
Although oligosaccharides of immunoglobulins have been studied extensively, most work has focused on myeloma proteins (Baenziger and Kornfeld, 1974a,b; Chapman and Kornfeld, 1979; Ishihara et al., 1983; Mellis and Baenziger, 1983; Takahashi et al., 1987) . It has been reported that the glycosylation of myeloma proteins may differ from their normal serum counterparts , and therefore the glycans present on the myeloma IgA proteins may not be representative of the normal serum population. In this study we performed a detailed oligosaccharide analysis of the N-glycans and the sialylated O-glycans released from normal serum IgAl.
In some disease states, most notably adult and juvenile rheumatoid arthritis (RA), the relative proportions of the IgG glycoforms are altered compared with the normal distribution (Rademacher et al., 1988; Rademacher, 1991) , and without the appearance of novel glycans. There is an increase in the incidence of N-glycans that terminate in N-acetylglucosamine and are devoid of non-reducing terminal fl-galactose residues (GO-type oligosaccharide chains) (Parekh et al., 1985) . In view of this, the terminal substitution (i.e. sialylation and galactosylation) of the N-glycans isolated from serum IgAl from a group of normal individuals was compared with IgA glycans from patients with RA to establish whether the alteration to the glycoform population is restricted to IgG or whether it also affects IgAl.
EXPERIMENTAL Materials
Jacalin lectin-agarose was obtained from Pierce, Chester, U.K. Antisera were from Sigma, Poole, Dorset, U.K. Enzymes were obtained as follows: bovine testes a-fucosidase (Sigma), bovine testes f8-galactosidase and Streptococcus pneumoniae 8l-Nacetylhexosaminidase (Boehringer-Mannheim), Arthrobacter ureafaciens neuraminidase (Calbiochem, Cambridge Bioscience, Cambridge, U.K.), endoglycosidase H (Streptomyces plicatus) (Miles Chemicals); Achatina fulica 8-mannosidase was a gift from Seikagaku Kogyo Co. (Tokyo, Japan). Choronia lampas afucosidase and almond emulsion ac-fucosidose III (Scudder et al., 1990; Butters et al., 1991) were purified in this laboratory. The sources of other enzymes have been described previously (Ashford et al., 1987; Olafson et al., 1990 (Parekh et al., 1985) .
Release of oligosaccharldes from IgAl and IgG
Immunoglobulins were dialysed exhaustively against distilled water (4°C), freeze-dried and cryogenically dried over activated charcoal at -196°C (<0.1 Pa). N-and 0-linked oligosaccharides were released with fresh double-vacuum-distilled anhydrous hydrazine and purified at 85°C, as described previously (Ashford et al., 1987; Parekh et al., 1989b; Olafson et al., 1990) .
'H-n.m.r. spectroscopy Samples were prepared for n.m.r. studies as described previously (Homans et al., 1984) . Briefly, neutral reduced oligosaccharides were passed through a tandem column containing 100,1u each of Chelex (Na+ form), AG50 (X12; HI form), AG3 (X4A; OHform) and QAE-Sephadex, and charged unreduced or reduced oligosaccharides were passed through a tandem column containing 100,ul each of Chelex (Na+ form) and AG50 (X12; H+ form). The samples were filtered through a 0.45,m-pore-diam. poly(tetrafluoroethylene) filter, evaporated to dryness and then dissolved in 2H20 before analysis by one-dimensional n.m.r. spectroscopy (600 MHz, 500 MHz or 300 MHz, using Bruker AM n.m.r. spectrometers).
Radiolabelling of oligosaccharides Purified oligosaccharides (1 mM glycan) were reduced with 6 mM NaB3H4 (specific radioactivity 10 Ci/mmol) at 30°C in 50 mM NaOH buffered to pH 11.0 with saturated boric acid. After 4 h, an equal volume of 1 M NaB3H4 in the same buffer was added and the reaction continued for a further 2 h. The oligosaccharides were subsequently purified from radiochemical contaminants as previously described (Ashford et al., 1987) .
Separation of oligosaccharides by charge
Anion-exchange chromatography Reduced and radiolabelled oligosaccharides were separated by anion-exchange chromatography using a Pharmacia f.p.l.c. system with a Mono Q HR5/5 column. Glycans were applied to the column in 200,ul of distilled water, and neutral species were eluted with water (2.5 column vol.). Charged oligosaccharides were eluted with a linear gradient of ammonium acetate, pH 5.5 (0-100 mM over 15 column vol.; flow rate 1 ml/min). Fractions (1 ml) were monitored by withdrawing portions for liquidscintillation counting to determine the relative proportions of differently charged species in IgA and to compare the sialic acid content of IgA and IgG. Peak charges were confirmed by analysis of pooled fractions by high-voltage electrophoresis (HVE).
Bio-Gel P-4 chromatography in salt Unreduced oligosaccharides were applied to a Bio-Gel P-4 (-400 mesh) gel-permeation chromatography column (1.5 cm x 1 m, maintained at 55°C) and eluted with 50 mM sodium acetate (pH 6.0, containing chlorbutol, 1 mg/ml). Glycans were detected by absorbance at 210 nm. The fractions were desalted on Dowex AG 5OW (X12; HI form).
Dionex BioLC ion-exchange chromatography
Pooled desalted oligosaccharide fractions from Bio-Gel P-4 chromatography were evaporated to dryness, redissolved in a minimum of water and injected on to a Dionex BioLC system equipped with a column (4.6 mm x 250 mm) of Dionex Carbo Pac PAl pellicular anion-exchange material (Dionex U.K. Ltd., Farnborough, Hants., U.K.). Separations were performed by elution with 100 or 200 mM NaOH at a flow rate of 1 ml/min; column temperature was 30 'C. Fractions (250 ,ul) of eluate were counted for radioactivity on a liquid-scintillation counter.
Separation of neutral oligosaccharldes
Glycans were converted into neutral compounds by treatment with 0.1 unit of Arthrobacter ureafaciens neuraminidase for 18 h in 60 ,1 of 0.1 M sodium acetate, pH 5.0, as determined by HVE for 45 min at 80 V/cm in pyridine/acetate/water (3:1:387, by vol.), pH 5.4. Reduced neutral oligosaccharides were fractionated by gel-filtration chromatography through Bio-Gel P-4 (-400 mesh) as previously described (Ashford et al., 1987; Parekh et al., 1989b; Olafson et al., 1990) . The eluate was monitored with an h.p.l.c. radioactivity monitor (Berthold model LB503) and in most cases also by withdrawing samples from the fractions for liquid-scintillation counting.
The hydrodynamic volume of the material eluted from the Bio-Gel P-4 columns was determined by comparison with coinjected isomaltose oligomer oligosaccharides (0.5 mg), monitored by refractive index, and is given in glucose units (gu).
Exoglycosidase digestions
Reduced and radiolabelled oligosaccharides were digested with exoglycosidases as described by Ashford et al. (1987 ), Parekh et al. (1989b and Olafson et al. (1990) with the following modifications. Jack-bean fl-galactosidase digestion was performed in a reaction volume of 30 1d containing 0.3 unit of enzyme. S. pneumoniae ,-N-acetylhexosaminidase digestion was performed at 8 munits/ml for linkage-specific digestions in 30 ,1u of 100 mM citrate phosphate buffer, pH 6.0, containing 1% BSA, or in a reaction volume of 20,1 at 0.3 unit/ml in 100 mM citrate phosphate buffer, pH 6.0, for arm-specific digestions. Digestion of glycans with bovine testes ,-galactosidase was performed in a reaction volume of 25 ,u containing 50 munits of enzyme in 100 mM citrate/phosphate buffer, pH 3.5. The specificity of all exoglycosidase reactions was confirmed by codigestions with standard oligosaccharides as described previously (Parekh et al., 1989b) .
Determination of the reduced terminus
The identity of the reducing terminal monosaccharide was determined by using the radioelectrophoretic method (Takasaki et al., 1982) . To confirm the identity of the reducing terminal (i.e. GalNAcOT and GlcNAcOT), the radiolabelled reducing terminal structures were also analysed by gas chromatography (radio-g.c.). Monosaccharides prepared by acid hydrolysis were first derivatized to the alditol acetates by incubating them with 10 ,ul of pyridine and 50 ,ul of acetic anhydride at 120°C for 20 min. After evaporation, 100 ,u of water and 100 ,u of chloroform were added. The aqueous layer was removed, and the chloroform layer evaporated. The peracetylated sample was then redissolved in chloroform, and a 1-2 #1 sample injected into a Varian 3600 g.c. system with a SP2380 capillary column (25 m x 0.32 m; Supelco). The sugars were eluted with helium (2.5 ml/min) at 90°C for 1 min. The temperature was raised at the rate of 30°C/min to 220°C, maintained for 13 min, and finally increased to 230°C at 30°C/min. Effluent from the g.c. column was mixed with hydrogen (3.5 ml/min), and passed into a catalytic reduction furnace (platinum catalyst/700°C) within the g.c. oven. The volatile reduction products were then mixed with counting gas [argon/methane (9:1, v/v); 120 ml/min], and radioactivity was detected in a 10 ml counting tube (Raytest, Sheffield, Yorks., U.K.). Retention times of unknown monosaccharide peaks were identified by comparing them with those of radiolabelled standards.
Determination of the Incidence of terminal galactose on IgA and IgG
The reduced desialylated glycans derived from IgAl were fractionated by gel filtration on Bio-Gel P-4 columns. Oligosaccharides which were eluted at hydrodynamic volumes greater than 10 gu were pooled and treated with a mixture ofjack-bean a-mannosidase, jack-bean f,-N-acetylhexosaminidase and bovine testes a-fucosidase as described by Parekh et al. (1988a) . This mixed enzyme digestion allows the resolution of complex-type oligosaccharides on Bio-Gel P-4 depending on the number of terminal /8-galactose residues they contain.
RESULTS
The overall scheme of analysis is described in Figure 1 .
Analysis of IgAl
IgAl was eluted from the h.p.l.c. gel-permeation column at a position consistent with a molecular mass of 160 kDa, and gave two major bands on reducing SDS/PAGE at 55 and 25 kDa (Figure 2 ). Immunoelectrophoresis detected only IgA when the purified material was blotted and challenged with anti-(human a-, y-and #u-chain). Cl esterase can co-isolate with jacalin-lectinpurified IgA (Loomes et al., 1991) . Cl esterase is present at approx. 200 ,cg/ml in normal human serum, about 10 % of the level of IgA, and contains six N-glycans/molecule, compared with four for IgA (Perkins et al., 1990) . Therefore without purification, Cl esterase oligosaccharides would contribute about 15 % to the pool of glycans analysed here. Cl esterase (95 kDa) was removed in the gel-filtration step which followed the affinity purification of IgAl (160 kDa), and it is estimated that the IgAl glycans analysed here are more than 95 % pure. Moreover, the glycans from Cl esterase, as determined in this laboratory (Perkins et al., 1990) , are very similar to those found on IgAl; 75 % corresponds to glycan A-c (see Figure 9) ; the remaining Cl esterase glycans are present at negligible levels.
Analysis of IgA glycans Charge analysis of total N-and O-glycans
Five IgA samples from normal individuals and five from patients with RA were analysed by Mono Q Sepharose ion-exchange chromatography. Figure 3 (a) is a representative chromatogram. The normal mean values were 14.0 + 3.6 % for neutral, 39.2 + 5.5 % for Al, 40.5 + 5.2 % for A2 and 6.3 +1 % for A3. The mean values for RA patients were 16.0 + 3.8 % for neutral, 35.1 + 3.0 % for Al, 43.4 + 6.0 % for A2 and 5.5 + 2.4 % for A3.
The Mono Q profile cannot be used to determine the ratio mono-/di-/tri-sialylated structures. Analysis of these fractions is shown in Figure 3 Figure 6c ). 0-linked structures eluted from the salt P-4 were analysed by exoglycosidase sequencing and Dionex ion-exchange chromatography, which was also used to confirm the Nglycan structures primarily determined from exoglycosidase sequencing co the hydrazinereleased, reduced, radiolabelled and desialylated glycans fractionated on aqueous P-4 ( Figure  8 ). disialylated 0-linked structures. This situation is the result of differences in charge contributions between a2-3-and a2-6-linked sialic acids.
Fractionation of total N-and O-glycans according to charge The complete set of oligosaccharide structures (N-and 0-linked) released by hydrazine from an individual sample of normal serum IgAl were chromatographed (before reduction) on a BioGel P-4 column eluted with salt ( Figure 3b ). Three fractions (A, B and C) were reduced with NaB3H4 and applied to a Bio-Gel P-4 column eluted with water ( Figure 3c ). In this latter system charged oligosaccharides were excluded from the gel and eluted at the void volume, and the neutral glycans were eluted according to their hydrodynamic volume. The oligosaccharides present in fractions A (56 % of total) and B (30 % of total) were all eluted in the void volume. In contrast, in fraction C (14% of total), 65 % of the oligosaccharides were eluted in the void volume (9 % of total IgA sugars), and a fraction (5 % of total IgA sugars) was eluted between 1)1 and 15 gu (Ca, Cb, C, Figure 3d ); these fractions contained the naturally occurring neutral N-glycans. In summary, 95 % of the oligosaccharide structures recovered from salt P-4 fractionation of this sample of normal IgA were charged and 5 % were neutral.
Exoglycosidase sequencing of natural neutral glycans from fraction C (GO-type oligosaccharides)
Fractions C., Cb and C, shown in Figure 3 (d) were analysed by Dionex chromatography (Figures 4a-4c ) and the major peaks from fraction Cc, which contained the GO-type sugars, were sequenced. The purified Dionex BioLC ion-exchange fractions of the naturally neutral fraction C, (Figure 4) were reapplied to the Bio-Gel P-4 column to confirm their hydrodynamic volumes (results not shown.) Peaks Cc1, C 2 and Cc4 were all single components eluted at 11.5 gu, whereas Cc3 contained two components which were eluted at 11.5 and 10.5 gu. Peaks Cc1 and CC2
were resistant to jack-bean a-mannosidase, indicating that they were complex-type oligosaccharides, whereas fraction Cc4 was completely digested to 5.5 gu (i.e. Man,84GlcNAcfi4GlcNAcOT),
indicating that this fraction contained the oligomannose structure Man8GlcNAe2. For each mannose residue beyond ManS, the hydrodynamic volume was between 0.85 and 0.9 gu. The oligosaccharides present in fraction CC3 were sensitive to amannosidase and digested to 9.0 gu, suggesting that the structures were hybrids. The major fraction, C2, was mixed with the GO standard GlcNAc/J2Mana6(GlcNAcfl2Mana3)Man,84Glc- oligosaccharide pool was applied to a Bio-Gel P-4 column eluted at 55 OC with sodium acetate containing chlorbutal. Fractions were pooled as indicated: A, 30%; B, 56%; C, 9%. The fractions were monitored by measuring absorbance at 210 nm; sialic acids absorb more strongly at this wavelength, therefore the peak areas do not represent the molar proportions of the glycans. These were determined, after radiolabelling, by HVE. (c) Aqueous Bio-Gel P-4 elution profile of fractions A, B and C from salt P-4. The oligosaccharides eluted in fractions A, B and C (b) were reduced with NaB3H4 and applied to Bio-Gel P-4 gel-filtration columns. The large void peak in each fraction contains the charged oligosaccharides; peaks C., Cb and Cc in fraction C contain the naturally neutral glycans. (d) An expansion of the naturally neutral glycans present in fraction C. Ca, Cb, Cc were analysed by Dionex chromatography; fraction Cc contains the GO-type oligosaccharides.
The numbers at the top indicate the elution position of glucose oligomers co-injected with the sample. (e) Biogel P-4 chromatogram of the oligosaccharides. The oligosaccharides eluted at Al, A2 and A3 in (a) were incubated with sialidase and applied to a Bio-Gel P-4 column.
treated with sialidase and subjected to Bio-Gel P-4 chromatglycans derived from HVE ( Figure 5a ) of fraction A (Figure 3c ). ography (Figure 6 Figure 6 (a) shows the P-4 elution profiles of the desialylated of material, fractions A5 and A6 were not analysed further. (Figure 3c ). Fraction Bi contained monosialylated biantennary and multiantennary N-linked structures. Fraction B2 contained three main peaks at 14.5 gu (48 %), 9.5 gu (22%) and 6.5 gu (30%). The 14.5 gu structures were an overlap of fraction A3. The 9.5 gu and 6.5 gu structures were monosialylated 0-linked structures. Fraction B3 was an overlap fraction ofA3. Fraction B4 contained monosialylated 3.5 gu O-glycans and was an overlap fraction from fraction C. Fractions BS and B6 contained disialylated 0-linked structures. (Figure 3c ). Structures eluted around 13.5 gu (25 %) were an overlap from fraction B (Figure 3b ). The 6.5 gu (42 %) and 3.5 gu (21 %) structures were derived from sialylated O-glycans.
Exoglycosidase sequencing analysis of acidic O-glycans fractionated by salt P-4/aqueous P-4/HVE/sialidase/aqueous P-4
The results of the enzyme digests are listed below (see also Figure  9 , structure O-b).
6.5 gu oligosaccharide present in fractions B5 and B2 (Figure 6b) and B (Figure 6c) The following data are consistent with the 6.5 gu species having the branched structure Gal/.4GlcNAc/36(Gal,83)GalNAcOT (Figure 9 , structure O-b), although the linear structure Galfl4GlcNAc,86Gal,/3GalNAcOT cannot be unambiguously ruled out. The 6.5 gu structure was resistant to jack-bean /3-Nacetylhexosaminidase, therefore no terminal GlcNAc was present. Digestion with S. pneumoniae /3-galactosidase gave a 5.5 gu product, indicating the presence of a terminal 4-linked galactose. The 5.5 gu product was resistant to S. pneumoniae /3-Nacetylhexosaminidase and to bovine testes /3-galactosidase. Incubation of the 5.5 gu structure with jack-bean /3-Nacetylhexosaminidase gave a product eluted at 3.5 gu, indicating the loss of a single 3-or 6-linked GlcNAc residue. The 3.5 gu product was sensitive to digestion with bovine testes /-galactosidase giving a product eluted at 2.5 gu. The reducing terminal oligosaccharide was confirmed as N-acetylgalactosaminitol by high-voltage borate electrophoresis. (Figure 6c ) The 3.5 gu species was shown to be Gal/J3GalNAcOT (Figure 9 , structure O-a) by a combination of exoglycosidase digestions and compositional analysis. Fraction B6 was disialylated and B4 was monosialylated. After neuraminidase treatment the neutral cores both ran at 3.5 gu.
The 3.5 gu structure was resistant to Escherichia coli ,-galactosidase (which cleaves only 4-linked galactose) but susceptible to bovine testes /8-galactosidase indicating terminal 3-linked galactose. The 2.5 gu fraction in B6 (Figure 6b ) was subjected to descending paper chromatography using pyridine/ ethyl acetate/water/acetic acid (5:5:1:3, by vol.) (not shown) and was resolved into three peaks. The major peak (80 %; Apc) and two minor peaks (10 %; Bpc) and (10 %; Cpc) were analysed for the presence of N-[3H]acetylgalactosaminitol by radio-g.c. The bulk of the radioactivity was not present in intact monosaccharides (results not shown.) Only the radioactivity in peak Cpc was found to be incorporated into N-acetylgalactosaminitol. The radioactivity in peaks Apc and Bpc therefore derived from chemically degraded 0-linked oligosaccharides still retaining a sialic acid residue.
Analysis of total N-glycans Dionex ion-exchange chromatographic analyses of N-glycans
The glycan structures from the Bio-Gel P-4 separations ( Figures  6a and 6b) were further fractionated by Dionex chromatography and compared with standard oligosaccharides. The information was used to confirm the exoglycosidase sequencing analyses of the desialylated N-glycans described in the next section. (Most results are not shown.) Figure 7 shows the Dionex chromatograms of fractions A4 (from Figure 6a) and Bla-g [from Bl (Figure 6b Exoglycosidase sequencing analysis of total N-glycans fractionated by aqueous P-4 gel filtration To determine the molar proportion of the different oligosaccharides present, the total asialo-oligosaccharide pool was treated with sialidase and the neutral oligosaccharides chromatographed on Bio-Gel P-4 columns (Figure 8 ). The four main fractions V, VI, VII and VIII were then treated with exoglycosidases to give digestive products characteristic of the proposed oligosaccharide structures present in each fraction. The highresolution Bio-Gel P-4 chromatogram of the N-linked oligosaccharides greater than 11 gu after sialidase treatment ( Figure  8 ) shows three subclasses of glycans. The elution volumes of peaks V-VII are consistent with biantennary complex or hybrid structures, whereas those for peaks I-IV are consistent with multiantennary structures or biantennary/hybrid complex structures containing repeating lactosamine units. Structures which were eluted at less than 13 gu (i.e. fraction VIII) included oligomannose, hybrid and incompletely galactosylated biantennary complex oligosaccharides. Fractions III-VIII from Figure 8 were subjected to detailed sequencing analysis, and in some cases the structures were confirmed by Dionex analysis of co-injected standard samples and by analysis of salt P-4 fractions. Triantennary structures (Table 1) Fractions and II Insufficient material was present for analysis.
Fraction Ill Exoglycosidase sequencing of the 17.2 gu peak gave data consistent with fraction III containing a triantennary complex structure (A-i) (Figure 9 ). There are three possible isoforms of this structure, in each of which the fucose is associated with a different arm of the trisaccharide. The degree of sialylation was determined from the position at which the glycan migrated in HVE before neuraminidase digestion. The 17.2 gu structure was found only in HVE fraction A2, the position at which the glycan migrated in HVE before neuraminidase digestion.
Fraction IV Exoglycosidase sequencing of the 16.4 gu peak gave data consistent with fraction IV containing the triantennary complex structure shown (A-h) (Figure 9 ). The 16.4 gu structure was predominantly found in HVE fraction A4, indicating that it was trisialylated. Fractions I-VIII were pooled as shown, and subjected to exoglycosidase sequencing as described in Figure 9 . The structures in each pool are also given in Figure 9 . Table 1 Oligosaccharides present in P-4 fractions Numbers in parentheses are the percentages determined by summation of the structures containing, e.g. + B + F listed in Figure 9 . n.d., Not determined; F, fucosylated; B, bisected. (Figure 9 ).
Fraction Blc (Figure 7 ) contained the monosialylated oligosaccharides eluted between 14.7 and 15.5 gu from Figure 6b (B1). The major fraction was eluted at 15.2 gu on rechromatography on Bio-Gel P-4 and co-eluted with the standard oligosaccharide Galf64GlcNAc/82Mana6(Gal,84GlcNAc,82Mana3)(GlcNAcfl4)-Man/J4GlcNAc,f4(Fucac6)GlcNAcOT on Dionex, confirming the structure of the major glycan in fraction V (A-a) (Figure 9 ).
Fraction VI
Exoglycosidase sequencing of the oligosaccharides eluted between 13.8 and 14.7 gu gave data consistent with fraction VI containing the biantennary complex structures A-b (82 %), A-d (12%) and A-a (6%) (Figure 9 and Table 1 ).
Fraction Bld (Figure 7 ) contained the monosialylated oligosaccharides eluted between 13.8 and 14.7 gu from fraction Bi (Figure 6b ). The structure eluted at 14.5 gu was co-eluted with the standard Gal,84GlcNAc,82Mana6(Galfl4GlcNAc,82Mana3)-Man,f4GlcNAcfl4 (Fuca6)GlcNAcOT Fraction VII Exoglycosidase sequencing of the structures eluted between 12.8 and 13.8 gu gave data consistent with fraction VII containing the biantennary complex structures A-f, A-e and A-c ( Figure 9 and Table 1 ).
Fraction Ble (Figure 7 ) represents the oligosaccharides eluted between 12.8 and 13.8 gu (Figure 6b ). The structure eluted at 13.5 gu on Bio-gel P-4 was co-eluted with the standard Gal,84GlcNAc,/2Mana6(Galfl4GlcNAc,82Mana3)Manfi4Glc-NAc,f4GlcNAcOT on Dionex consistent with the data above (structure A-c) (Figure 9 ).
Fraction VIII
Exoglycosidase sequencing of the oligosaccharides eluted between 11.2 and 12.8 gu gave data consistent with the fractions containing structures A-f and A-g (Figure 9 ), with oligomannose (11 %) and hybrid-type (14%) structures respectively (Table 1) .
Fraction Blg (Figure 7 ) also contains oligosaccharides eluted at 11.8 gu ( Figure 6b ). As these structures were recovered from a monosialylated fraction, they must have been derived from structures containing a terminal sialyl-Gal linkage and therefore probably represent hybrid-type oligosaccharides or truncated monoantennary oligosaccharides. Owing to the small amount of material available, these fractions were not further analysed.
Analysis of core types Cores V and VI
To confirm the ratios of fucosylated (F) and bisected (B) oligosaccharides in the major fractions, fractions V and VI (Figure 8) Figure 9 For legend see opposite. Analysis of individual fractions used a combination of sequential exoglycosidase digestion and P-4 gel-permeation chromatography. Changes in the hydrodynamic volume of oligosaccharides were effected by exoglycosidases when used in the following order: oligosaccharide A-a, 3-4-5-3-1-7-8-3; oligosaccharide A-b, 3-4-5-1-7-8-3; oligosaccharide A-c, 3-4-5-7-8-3; oligosaccharide A-d, 3-6-5-3-7-8-3; oligosaccharide A-e, 3-7-4-3-7-8-3; oligosaccharide A-f, 6-5-7-8-3; oligosaccharide A-g, 5-7-8-3; oligosaccharide A-h, 3-2-3-7-8-3, also 2-5-3-7-8-3; oligosaccharide A-i, 3-9-2-5-3-7-8-3, also 3-2-9-2-5-3-7-8-3; oligosaccharide O-a, 4; oligosaccharide O-b, 3-6-3-4. 1, Choronia lampus a-fucosidase; 2, jack-bean ,7-galactosidase; 3, jack-bean f8-N-acetylhexosaminidase; 4, bovine testes /8-galactosidase; 5, S. pneumoniae ,8-N-acetylhexosaminidase; 6, S. pneumoniae ,8-galactosidase; 7, jack-bean a-mannosidase; 8, Achatina fuilca fJ-mannosidase; 9, almond emulsion afucosidase Ill.
7.5 gu structure (10%)] were digested with jack-bean amannosidase followed by snail fl-mannosidase followed by jackbean fl-N-acetylhexosaminidase. The final products eluted at 3.5 gu (Fuca6GlcNAcOT) and 2.5 gu (GlcNAcOT) were subjected to either chemical or enzymic defucosylation. The 3.5 gu structure gave a single product at 2.5 gu, confirming that the reducing terminal, GlcNAc, was substituted with the fucose residue.
Cores V, VI, VII and VIII To confirm the ratios of fucosylated (F) and bisected (B) oligosaccharides, fractions V-VIII ( Figure 8) Incidence of terminal galactose of paired IgG and IgA samples It was found that 95 % of the oligosaccharides associated with IgA were of the complex type, and therefore amenable to analysis with mixed exoglycosidases. Of these complex sugars, 86 % were biantennary structures such as are present on IgG, and 140%
were of the triantennary complex type. The IgG glycans were treated with mixed exoglycosidases, and three peaks were resolved by Bio-Gel P-4 gel filtration, as reported previously (Parekh et al., 1988b) . The IgAl N-glycans, subjected to the same treatment, which were resolved into five peaks by Bio-Gel P-4 gel filtration, eluted at 16.5, 13.5, 11.5 (trace), 10.5 and 7.5 gu. With Table 2 Galactosylation of IgAl and IgG from patients with RA IgAl and IgG were isolated from serum and the N-glycans released, purified and radiolabelled as described in the Experimental section. A portion of the glycans from each preparation was digested with a mixture of exoglycosidases to allow resolution of the species containing zero to three terminal #J-galactose residues, and the products were separated on Bio-Gel P-4. Figure 1Oa ).
An estimate of the charge distribution of the glycans of IgA from normal and RA patients was determined using Mono Q Sepharose; no differences were found (the results are summarized in Figure lOb) (Table 3 and Figure 10 ).
Comparison with other immunoglobulins IgM, IgD, IgE
No evidence was found for significant levels of oligomannose glycans (i.e. > 5 %), which have been reported for human IgM, IgD and IgE (Chapman and Kornfeld, 1979; Ishihara et al., 1983; Rearick et al., 1983 (Figure 9 ). In the present 0"l c cJ (Mizoguchi et al., 1982; Pierce-Cretel et al., 1982 . In contrast with serum IgA, the acidic oligosaccharides of sIgA are not bisected (Pierce-Cretel et al., 1982) . Three extensions of the basic biantennary structure were found on sIgA: a fucose in al-3 linkage to GlcNAc-5', a galactose residue in,/1-3 linkage to the terminal Gal on the Gal 6' and a fucose in al-6 linkage to GlcNAc-5'. Both neutral biantennary N-acetyl-lactosamine-type and extended biantennary N-acetyl-lactosamine-type structures extended by additional fucosyl N-acetyl-lactosamine-type structures are present on sIgA (Pierce-Cretel et al., 1982) , some of which may be derived from the secretory component (Mizoguchi et al., 1982) . The presence of fucosyl-N-acetyl-lactosamine structures on serum IgA 1, as reported here, suggests that either serum contains an appreciable quantity of sIgA or serum IgAl has some oligosaccharide structural characteristics in common with sIgA. However, the presence of a trisialylated triantennary structure on serum IgAl and the recovery of oligosaccharides containing the fucosyl-N-acetyl-lactosamine group in a sialic acid-containing fraction, rather than in the neutral fraction as for sIgA, suggests a unique glycosylation pattern for serum IgAl. Although we have not been able to establish whether the sialyl a(2-3) Lewis X group is present, its occurrence on IgAl would potentially give IgA a unique effector function amongst the immunoglobulins.
Serum IgA 0-linked structures
We have previously reported that approx. 64% of O-glycans released by f-elimination from normal serum IgA were sialylated (Field et al., 1989) and 19 % were the monosaccharide GalNAc. However, the predominant structure present (54 %) was NeuNAc2a3Gal,#3GalNAc, and 10 % of the disialylated species was also recovered. In the present study, the sugars were released by hydrazine at 85°C, and only sialylated 0-linked structures were recovered; 64 % were NeuAc2a3Gal,/3(NeuAc2a6)GalNAc and 90% were the disialylated form of Gal, 84GlcNAc #6(Gal,83)GalNAc. In our experience the 0-linked structures recovered from IgA depend on the methods used to release and purify the oligosaccharides. The pattern of0-linked glycosylation reported here is more similar to that found on the hinge region of SIgA obtained from human milk (Pierce-Cretel et al., 1981) than to the IgAl myeloma in which Baenziger and Kornfeld (1974b) reported the presence of only the neutral Gal, 83GalNAc and GalNAc oligosaccharides.
IgA and RA Increased levels of incompletely galactosylated IgG are observed in a restricted group of diseases (Parekh et al., 1989a) , including juvenile (Parekh et al., 1988b) and adult (Parekh et al., 1985) RA. N-Glycans from five normal and five RA IgAl serum samples were analysed for similar RA-associated alterations in glycosylation. The incidence of glycans terminating in 0-3 /,-galactose residues (GO, GI, G2, G3) was remarkably constant, despite a wide variation in the galactosylation of IgG isolated from the same serum (Table 2 ). The incidence of galactosylation is much greater for IgAl glycans than for IgG glycans. For the entire study group, IgAl GO varied between 1.1 and 2.7 %, whereas the IgG GO varied between 16 and 47 %. We note that on a percentage basis the increase in GO for IgA between normal (1.3 %) and RA (2.3 %) is essentially the same as for the increase in GO found for IgG between normal (20 %) and RA (40%).
Although it cannot be ruled out that there may be a small percentage of IgA clones that secrete GO IgA and that the number of these clones has doubled in patients with RA, it seems unlikely that a 1 % increase in GO IgA in patients with RA would be of physiological significance.
The lower levels of IgG galactosylation associated with RA may result from decreased levels of galactosyltransferase (Axford et al., 1992) . Given the high levels of fully galactosylated glycans associated with IgAl, this effect would be expected to be much more pronounced. That it is not supports the conclusion that the alteration in galactosyltransferase levels is restricted to those cells making IgG, or some other mechanism is involved.
The conformation of the IgG Fc polypeptide may play an important role in regulating the processing of N-glycans (Schachter, 1986; Lee et al., 1990) . Crystallographic studies have shown that the two CH2 domains in IgG do not form extensive lateral associations. The resulting interstitial region accommodates the complex oligosaccharides which are attached to Asn-297 on each heavy chain such that one of the a-(1,3) antennae interacts with the trimannosyl core of the opposing oligosaccharide. The a(I-6) antennae interact with hydrophobic and polar residues on the domain surface. It has been proposed that this restricts the addition of both galactose and sialic acid to the Fc oligosaccharides and is supported by the observation that glycans associated with the Fab fragment of human IgG are more sialylated and galactosylated than the oligosaccharides associated with the Fc fragment (Rademacher et al., 1986) . In the case of IgA 1, there are two sequons positioned in the Fc, at Ca2 (Asn-263) and Ca3 (Asn-459), neither of which is at a position comparable with the site on IgG (Young et al., 1990 (Kerr, 1990) . If the IgG glycans are partially inaccessible to macromolecular ligands by being sterically shielded, then IgG carrying incompletely substituted glycans may evade regulatory mechanisms that in vivo are responsible for either preventing secretion or for removing such glycoproteins from the circulation (Wilson et al., 1993) . In the case of IgAl, the positions of the sequons suggest that the glycans are not shielded by the polypeptide (Young et al., 1990) , and the high incidence of both sialic acid and galactose on these glycans is strong evidence that there is no restriction to the access of the relevant glycan-processing enzymes (Shao et al., 1987) . This suggests that the oligosaccharides are potential ligands, and therefore more complete construction of the IgA1 oligosaccharides may not only be possible but necessary to ensure efficient secretion, a reasonable serum half-life and to prevent autoimmune stimulation which may result from the exposure of unusual oligosaccharide determinants.
It will be interesting to determine whether IgAl glycosylation is altered in other disease states, such as those in which IgG glycosylation has been shown to alter (e.g. tuberculosis or Crohn's disease) or where there is no evidence for an IgG-related disorder (e.g. IgA nephropathy).
Note added in proof (Received 8 February 1994) Since submission of this manuscript Boren et al. (1993) have reported that the H-2 antigen (terminal Fuca I -2Gal) is present on serum IgA. This conclusion was drawn from the observation that serum IgA binds Ulex europaeus type-I lectin on a Western blot. We do not report the presence of either Lewisy (Ley) (contains Fucal-2Gal and Fucal-3GlcNAc) or H-2. Our results do not exclude the possibility that these glycans are present, but suggest that they are at very low levels. Ley would elute in fractions I and II (Figure 8 ), which contained very low amounts of oligosaccharides. H-2 would elute in fraction III and was not observed, suggesting that it exists at levels lower than the limits of detection of this technique.
Also in this paper we report that serum IgA contains low amounts of Lewisx (Lex) . This is compatible with the observation by Boren et al. (1993) that IgA recognizes Aleuria aurantia lectin as in addition to binding core fucose this lectin also binds weakly to outer-arm fucose residues (Furukawa and Kobata, 1993) .
